Fureasu (7062) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The key highlight for the cumulative Q3 period of the fiscal year ending March 2026 was the return to operating profitability, with improved earnings driven by both revenue growth and an improved cost structure. Revenue was ¥6.16B (¥5.56B in the same period of the previous year, +10.9%), while Operating Income improved to ¥0.19B, compared with an Operating Loss of ¥0.08B in the previous year, resulting in a return to profitability. Ordinary Income was ¥0.25B and Net Income was ¥0.39B (compared with a Net Loss of ¥0.19B in the previous year). However, Net Income was supported by ¥0.30B in extraordinary gains, including a ¥0.28B gain on the transfer of a business, and it should be noted that most of this uplift was attributable to non-recurring factors.

Factors Behind Earnings Fluctuations

【Revenue】Revenue increased 10.9% year on year to ¥6.16B. By segment, Massage Directly Operated increased to ¥3.15B (51.1% of total revenue, +4.5% year on year), while Massage Franchising expanded to ¥0.89B (14.4% of total revenue, +19.1%). Medical Care, however, declined to ¥2.11B (34.3% of total revenue, -2.1%). Growth in the two core segments led the overall revenue increase.

【Profit and Loss】The gross profit margin improved to 45.0% from 43.1% in the previous year, while the SG&A ratio declined to 42.0% from 44.4%. As a result, the Operating Income margin improved to 3.0% from -1.4%, marking a return to profitability. Ordinary Income was ¥0.25B, supported by non-operating income, including ¥0.15B in subsidy income. Net Income of ¥0.39B was boosted by ¥0.30B in extraordinary gains, including a ¥0.28B gain on the transfer of a business, and should be assessed separately from the improvement in recurring earnings power. Overall, the company recorded higher revenue and profits, but the 3.0% Operating Income margin still leaves room for improvement.

Segment Analysis

Massage Directly Operated was the largest source of earnings, generating segment profit of ¥0.91B and a profit margin of 29.0%. Franchising also maintained high profitability, with profit of ¥0.26B and a profit margin of 29.1%. Medical Care, meanwhile, continued to report a segment loss of ¥0.20B (profit margin of -9.5%). Although the loss narrowed from ¥0.49B in the same period of the previous year, the segment remains in the red and is a constraint on the consolidated Operating Income margin. Organizational restructuring is under way to consolidate home-visit nursing operations into Medical Care.

Key Financial Metrics

【Profitability】The Operating Income margin improved to 3.0% from -1.4% in the previous year, but remains below 5%. The Net Income margin improved significantly to 6.3% from -3.5% in the previous year, although it was heavily affected by extraordinary gains, including the gain on the transfer of a business.【Cash Flow Quality】Ordinary Income was only ¥0.25B compared with Profit Before Tax of ¥0.55B, with the gap mainly attributable to ¥0.30B in extraordinary gains.【Investment Efficiency】Annualized ROE was high at 25.1%, but it cannot be considered a recurring level after taking into account the impact of one-time gains included in Net Income. Total assets decreased from ¥8.70B in the previous year to ¥5.73B, meaning that asset reduction also contributed to the apparent improvement in asset efficiency.【Financial Soundness】The Equity Ratio improved significantly to 35.9% from 17.5% in the previous year, while cash and deposits increased to ¥1.59B. Although the current ratio was favorable at approximately 205%, interest coverage remained limited at approximately 2.1x against interest expense of ¥0.09B, indicating that debt-servicing capacity remains constrained.

Cash Flow Analysis

Although a cash flow statement was not disclosed, an analysis of funding trends based on changes in the balance sheet indicates that cash and deposits increased 94.7% from ¥0.81B in the previous year to ¥1.59B. Property, plant and equipment declined substantially to ¥0.65B, while lease assets and lease liabilities also contracted significantly, suggesting that asset reduction through the transfer of a business contributed to the accumulation of cash. Long-term borrowings declined from ¥0.68B to ¥0.40B, indicating progress in reducing interest-bearing debt from a financial perspective. However, short-term borrowings increased to ¥0.95B, resulting in a debt structure biased toward the short term. Retained earnings increased from ¥0.91B to ¥1.30B, and the retention of Net Income also supported the accumulation of equity.

Quality of Earnings

The improvement in earnings for the current period consisted of both structural improvements—resulting from a higher gross profit margin and a lower SG&A ratio at the operating level—and the non-recurring impact of ¥0.30B in extraordinary gains, including a ¥0.28B gain on the transfer of a business. Ordinary Income of ¥0.25B was formed by adding non-operating income, including ¥0.15B in subsidy income, to Operating Income of ¥0.19B; this also warrants attention from a sustainability perspective. Ordinary Income was only ¥0.25B compared with Profit Before Tax of ¥0.55B, with the difference mainly attributable to extraordinary gains. Accordingly, it is not appropriate to evaluate Net Income of ¥0.39B or ROE of 25.1% as recurring earnings power without adjustment. It is reasonable to view the underlying profit level excluding extraordinary gains as being close to Ordinary Income of ¥0.25B.

Earnings Forecast and Guidance

Progress toward the full-year forecast was strong, with Revenue at 79.9% (forecast: ¥7.72B), Ordinary Income at 87.8% (forecast: ¥0.29B), and Net Income at 98.2% (forecast: ¥0.40B). Operating Income, however, stood at 63.6% of the forecast (forecast: ¥0.29B), below the standard progress benchmark of 75%. The high progress rate for Net Income was largely attributable to the gain on the transfer of a business. For an assessment of full-year underlying earnings power, the focus will be on Q4 Operating Income, with approximately ¥0.11B required to achieve the full-year plan. No revisions were made to the earnings forecast or dividend forecast during the current quarter.

Shareholder Returns

The Q2 dividend was ¥0 per share, and the full-year dividend forecast is also ¥0, resulting in a Payout Ratio of 0%. Retained earnings increased from ¥0.91B in the previous year to ¥1.30B, with profits being retained to strengthen the financial position. Given the high proportion of short-term liabilities in the financial structure, capital allocation priorities at present appear to be stable management of borrowings and strengthening of the financial base.

Risk Factors

1. Delay in improving the profitability of the Medical Care Business: Despite Revenue of ¥2.11B, representing 34.3% of consolidated revenue, the segment continues to report a loss of ¥0.20B. Although the loss narrowed from ¥0.49B in the previous year, a delay in achieving profitability would constrain improvement in the consolidated Operating Income margin.

2. Refinancing and debt-servicing capacity risk: While short-term borrowings increased to ¥0.95B, interest coverage against interest expense of ¥0.09B remained at approximately 2.1x. Depending on changes in the interest-rate environment and refinancing terms, financial expenses may increase.

3. Dependence on temporary gains: Of Net Income of ¥0.39B, ¥0.30B in extraordinary gains, including a ¥0.28B gain on the transfer of a business, made a significant contribution. Subsidy income of ¥0.15B also boosted Ordinary Income. Excluding these factors, recurring earnings power remains limited.

Industry Benchmark (For Reference; Company Analysis)

Profitability and Returns

The Operating Income margin is significantly below the industry median, while the Net Income margin is slightly above the median, partly due to the contribution from extraordinary gains.

Growth and Capital Efficiency

The Revenue growth rate is broadly in line with the industry median.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. Operating earnings returned to profitability, confirming the emergence of operating leverage through gross margin improvement and SG&A control. However, the 3.0% Operating Income margin remains below the industry median of 8.3%, leaving room for further improvement in earnings power.

2. The core Massage Directly Operated and Franchising businesses both delivered high profit margins of approximately 29%, while Medical Care continued to report a segment loss of ¥0.20B. Accordingly, improvement in the profitability of this business will determine the future direction of the consolidated profit margin.

3. Net Income of ¥0.39B and annualized ROE of 25.1% depend heavily on extraordinary gains, including a ¥0.28B gain on the transfer of a business. When evaluating recurring earnings power, Ordinary Income of ¥0.25B and Operating Income of ¥0.19B should be used as the benchmarks.

Theoretical Share Price (Reference Value)

Sensitivity: ¥1,041–¥1,107 at ±1% for the cost of equity, and ¥1,065–¥1,085 at ±0.1 for ω.

Notes:

• Because progress toward the full-year Net Income forecast (98%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a maximum range of +10% (because companies whose progress is ahead of schedule tend to exceed their forecasts. The adjustment may be excessive for businesses with strong seasonality).
• Net assets as of the quarter-end have been used (there is a timing difference from the full-year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest Rate Reference Month: 2026-08 / Mechanically calculated using only publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting with professionals as necessary.

---End of Report---